Going for gold: Nanotech design opens door to new cancer treatments

To develop cancer drugs, researchers often have to make tough trade-offs. Most drugs potent enough to kill tumors also cause unpleasant side effects—and may end up doing more harm than good. Now, researchers and clinicians at Stevens Institute of Technology and Hackensack Meridian Health have developed a new drug delivery system that uses gold nanoparticles to deliver drugs to tumors with remarkable precision—while dramatically reducing the potential for systemic side-effects.